Empower Your Pharmaceutical Decisions with IntelRx.

Oncology practices often don’t have the intelligence to make data-supported decisions when it comes to pharmaceuticals. These decisions – and the information that informs them – should be straightforward. The cost and the reimbursement of each pharmaceutical should be clear-cut. But dealing with complex fee schedules with versions for every payer and National Drug Code variations leave these decisions feeling complex and convoluted.

For practice and pharmacy leadership who need to keep their practices sustainable, IntelRx provides complete, real-time data to make pharmacoeconomic decisions, allowing a financial lens to complement an otherwise clinical decision.